Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06475235 | Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL | ||
| NCT04899908 | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases | ||
| NCT00165360 | Prolonged Daily Temozolomide for Low-Grade Glioma | ||
| NCT00580242 | A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia | ||
| NCT03681483 | RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer | ||
| NCT00146562 | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | ||
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | ||
| NCT07412041 | Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study | ||
| NCT03070145 | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy | ||
| NCT04406272 | VB-111 in Surgically Accessible Recurrent/Progressive GBM | ||
| NCT03657628 | Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue | ||
| NCT00095836 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | ||
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | ||
| NCT04851522 | Dilute Bleach Compresses for Radiation Dermatitis | ||
| NCT06518551 | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM | ||
| NCT00090857 | Letrozole in Preventing Breast Cancer in Postmenopausal Women | ||
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | ||
| NCT05080166 | UPLYFT For Lymphoma Survivors | ||
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | ||
| NCT01523977 | Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL | ||
| NCT01670500 | Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa | ||
| NCT00361309 | SU011248 in Advanced Hepatocellular Carcinoma | ||
| NCT03425331 | Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC | ||
| NCT03410875 | A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia | ||
| NCT00809588 | Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF) | ||
| NCT04028531 | Understanding Chronic Lymphocytic Leukemia | ||
| NCT01058239 | Bortezomib Plus Rituximab for EBV+ PTLD | ||
| NCT05210101 | A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals | ||
| NCT02135211 | Healthy Directions After Lung Surgery Pilot | ||
| NCT00426205 | GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | ||
| NCT02201212 | Everolimus for Cancer With TSC1 or TSC2 Mutation | ||
| NCT03170648 | Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study | ||
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 | ||
| NCT05703542 | BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome | ||
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT06100874 | A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) | ||
| NCT05383196 | Onvansertib + Paclitaxel In TNBC | ||
| NCT04584255 | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer | ||
| NCT06716580 | EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations | ||
| NCT01058655 | RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer | ||
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | ||
| NCT03426878 | Cancer Health Assessments Reaching Many | ||
| NCT01566890 | Microvascular Blood Flow in Sickle Cell Anemia | ||
| NCT01380782 | BIBF 1120 for Recurrent High-Grade Gliomas | ||
| NCT02195232 | Cancer Associated Thrombosis and Isoquercetin (CATIQ) | ||
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | ||
| NCT06564233 | Supportive Care Intervention for Outpatient Stem Cell Transplant Patients | ||
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | ||
| NCT03417544 | Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC | ||
| NCT01342978 | Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time |
